Moderate

Cancer pain — WHO analgesic ladder & opioid conversion (opioid titration, opioid rotation)

Palliative / symptom control · Geriatric & General
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Structured analgesia for cancer and other severe chronic pain using the WHO analgesic ladder, with regular (background) analgesia, as-required (breakthrough) doses, and adjuvants. Most cancer pain is controllable with oral morphine titrated to effect plus laxatives and antiemetics. Safe practice requires correct opioid conversion when switching drug or route, dose reduction for incomplete cross-tolerance on rotation, and vigilance for toxicity (especially in renal impairment and frailty). Conversion ratios below are approximate guides — verify against local formulary and specialist advice.

Red flags

  • New severe back pain with neurology — malignant spinal cord compression (emergency: dexamethasone + urgent MRI)
  • Sudden severe pain — pathological fracture, haemorrhage, perforation, obstruction
  • Opioid toxicity: drowsiness, confusion, myoclonus, pinpoint pupils, RR <8 — reduce dose / rotate / naloxone if severe
  • Rapidly escalating requirements (reassess cause; consider neuropathic/incident pain, psychological distress, tolerance)
  • Renal impairment on morphine — risk of metabolite accumulation and toxicity (switch to oxycodone/fentanyl/alfentanil)

Assessment

Differential diagnosis

  • Characterise pain: nociceptive somatic (bone, soft tissue), nociceptive visceral, neuropathic (burning, shooting, dermatomal), or mixed
  • Incident/breakthrough vs background pain; total pain (psychological/spiritual/social contribution)
  • Oncological emergencies causing pain: malignant spinal cord compression, pathological fracture, bowel obstruction, raised ICP

Investigations

  • Pain assessment: site, severity (0-10), character, radiation, temporal pattern, exacerbating/relieving, impact; reassess regularly
  • Renal and hepatic function (U&E, LFTs) — guides opioid choice and dose (avoid/adjust morphine in renal failure)
  • Calcium (bone pain/hypercalcaemia), FBC
  • Imaging targeted to cause (X-ray/MRI for bone pain, cord compression)

Management

  • Step 1 (mild): non-opioid — paracetamol +/- NSAID (+ PPI) + adjuvant
  • Step 2 (mild-moderate): weak opioid (codeine, dihydrocodeine, low-dose morphine) + non-opioid + adjuvant — many guidelines now move to low-dose strong opioid directly
  • Step 3 (moderate-severe): strong opioid (oral morphine first-line) + non-opioid + adjuvant
  • Titrate: start regular immediate-release morphine (e.g. 5 mg 4-hourly, lower in elderly/renal impairment) + breakthrough dose = 1/6 to 1/10 of total 24-h dose, as required
  • After 24-48 h, convert the total daily requirement (regular + breakthroughs) to a modified-release preparation, recalculate the breakthrough dose
  • ALWAYS co-prescribe a regular stimulant +/- softener laxative and an as-required antiemetic for the first days
  • Add adjuvants by pain type: neuropathic — amitriptyline/duloxetine/gabapentin/pregabalin; bone pain — NSAID, bisphosphonate, consider radiotherapy; raised ICP/nerve compression/liver capsule — dexamethasone
  • Opioid rotation (for toxicity/inadequate effect): convert to equianalgesic dose of new opioid then REDUCE by 25-33% for incomplete cross-tolerance, and re-titrate
  • Switch to subcutaneous route (CSCI/syringe driver) if unable to swallow, vomiting, or last days of life — convert dose appropriately
  • Monitor for toxicity: sedation, confusion, myoclonus, pinpoint pupils, respiratory depression, hallucinations (consider accumulation/renal impairment)

Drugs & doses

Paracetamol 1 g PO/IV four times daily (max 4 g/day; reduce if <50 kg or hepatic impairment) [verify local dose]
Codeine 30-60 mg PO four times daily (max 240 mg/day); approx oral morphine equivalent = divide codeine by 10 (codeine 240 mg/day ~ oral morphine 24 mg/day) [verify local]
Tramadol 50-100 mg PO up to four times daily (max 400 mg/day); approx 1/10 potency of oral morphine (tramadol 400 mg ~ oral morphine 40 mg) [verify local]
Immediate-release oral morphine 5 mg PO 4-hourly + 1/6-1/10 of 24h dose for breakthrough (start 2.5 mg or avoid in significant renal impairment) [verify local dose]
Modified-release oral morphine (e.g. 10-15 mg PO twice daily) once daily requirement established [verify local dose]
CONVERSIONS (approximate, verify locally): oral morphine to SC morphine divide by 2; oral morphine to SC diamorphine divide by 3; oral morphine to oral oxycodone divide by ~1.5-2; oral oxycodone to SC oxycodone divide by 2
Oxycodone (oral) — alternative strong opioid if morphine not tolerated; immediate-release 2.5-5 mg as equivalent, MR twice daily [verify local dose]
Transdermal opioids for stable pain: fentanyl 12 microgram/h patch ~ oral morphine ~30-45 mg/24h; buprenorphine patch for lower doses/renal impairment (use conversion chart; NOT for rapid titration) [verify local dose]
Adjuvants — neuropathic: amitriptyline 10-25 mg PO at night, or duloxetine 30-60 mg daily, or gabapentin/pregabalin titrated [verify local dose]
Dexamethasone 4-8 mg PO/SC once daily for nerve compression/raised ICP/liver capsule/bone pain (give early in day) [verify local dose]
Laxative (co-prescribe): senna 7.5-15 mg + macrogol/docusate; antiemetic: haloperidol 1.5 mg or metoclopramide 10 mg as required [verify local dose]

Disposition

Manage in community/oncology/palliative care; involve specialist palliative care for complex, escalating, or neuropathic pain, for opioid rotation, and for conversion to syringe driver. Admit for uncontrolled pain or oncological emergency.

Complications & pitfalls

  • Opioid-induced constipation (near-universal — always prescribe laxative), nausea, sedation
  • Opioid toxicity/accumulation (esp. renal failure, overaggressive titration, conversion errors)
  • Respiratory depression (rare with careful titration for pain)
  • Under-treated pain from opioid-phobia; NSAID GI/renal/CV toxicity
  • Errors in opioid conversion causing overdose — a major patient-safety hazard

Exam pearls

  • Guidance: WHO analgesic ladder; NICE CG140 (opioids in palliative care); Scottish Palliative Care Guidelines; Palliative Care Formulary (PCF).
  • On opioid ROTATION, after calculating the equianalgesic dose, reduce by 25-33% for incomplete cross-tolerance and re-titrate.
  • Oral morphine to SC morphine = divide by 2; oral morphine to SC diamorphine = divide by 3 — these are the two conversions to memorise, but always double-check.
  • In renal impairment avoid morphine (active metabolites accumulate) — use oxycodone, fentanyl or alfentanil.
  • Co-prescribe a laxative with every strong opioid and an antiemetic for the first week; breakthrough dose = 1/6-1/10 of 24-h dose.
  • Use the NHS Specialist Pharmacy Service / local opioid conversion tool for every switch.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.